Nothing Special   »   [go: up one dir, main page]

Poupardin et al., 2021 - Google Patents

Adherence to minimal experimental requirements for defining extracellular vesicles and their functions

Poupardin et al., 2021

View HTML
Document ID
2853928185156940039
Author
Poupardin R
Wolf M
Strunk D
Publication year
Publication venue
Advanced Drug Delivery Reviews

External Links

Snippet

Rigorous measures are required to cope with the advance of extracellular vesicle (EV) research, from 183 studies published in 2012 to 2,309 studies published in 2020. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/536Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4077Concentrating samples by other techniques involving separation of suspended solids

Similar Documents

Publication Publication Date Title
Poupardin et al. Adherence to minimal experimental requirements for defining extracellular vesicles and their functions
Welsh et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Sluijter et al. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology
Ter-Ovanesyan et al. Framework for rapid comparison of extracellular vesicle isolation methods
De Sousa et al. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy
Soekmadji et al. The future of Extracellular Vesicles as Theranostics–an ISEV meeting report
Butt et al. A molecular mechanism explaining albuminuria in kidney disease
Brown et al. Hidden killers: human fungal infections
Karimi et al. Detailed analysis of the plasma extracellular vesicle proteome after separation from lipoproteins
Onódi et al. Isolation of high-purity extracellular vesicles by the combination of iodixanol density gradient ultracentrifugation and bind-elute chromatography from blood plasma
Iwai et al. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations
Hollander et al. High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Dear et al. Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling
Mathivanan et al. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature
Yuana et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma
Grigor’Eva et al. Contamination of exosome preparations, isolated from biological fluids
Wang et al. Human CD4+ lymphocytes for antigen quantification: characterization using conventional flow cytometry and mass cytometry
Bulgarelli et al. Dendritic cell vaccination in metastatic melanoma turns “non-T cell inflamed” into “T-cell inflamed” tumors
Philogene et al. Differential effect of bortezomib on HLA class I and class II antibody
US12038434B2 (en) Devices, solutions and methods for sample collection related applications, analysis and diagnosis
Kaddour et al. The past, the present, and the future of the size exclusion chromatography in extracellular vesicles separation
Anderson et al. Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma
Nelson et al. Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors
Tang et al. Bronchus-associated macrophages efficiently capture and present soluble inhaled antigens and are capable of local Th2 cell activation
Fourtounas et al. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients